Holen Sie sich die Stockscreener-App
3.87
0.52%
0.02
Handel nachbörslich:
3.85
-0.02
-0.52%
Schlusskurs vom Vortag:
$3.85
Offen:
$3.885
24-Stunden-Volumen:
875.98K
Relative Volume:
0.89
Marktkapitalisierung:
$220.49M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-82.44M
KGV:
-2.0585
EPS:
-1.88
Netto-Cashflow:
$-66.75M
1W Leistung:
-2.52%
1M Leistung:
-1.53%
6M Leistung:
+92.54%
1J Leistung:
+54.18%
1-Tages-Spanne:
$3.67
$3.895
1-Wochen-Bereich:
$3.665
$4.055
52-Wochen-Spanne:
$1.195
$4.94
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Firmenname
Black Diamond Therapeutics Inc
Sektor
Branche
Telefon
617-417-5868
Adresse
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Vergleichen Sie BDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
3.87 | 219.35M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-10-16 | Fortgesetzt | Stifel | Buy |
| 2025-09-04 | Eingeleitet | Guggenheim | Buy |
| 2025-07-01 | Fortgesetzt | Raymond James | Outperform |
| 2024-07-31 | Eingeleitet | Raymond James | Outperform |
| 2023-07-14 | Eingeleitet | Piper Sandler | Overweight |
| 2023-06-30 | Hochstufung | Stifel | Hold → Buy |
| 2023-06-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-03-29 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-03-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Stifel | Hold |
| 2021-01-07 | Eingeleitet | Wedbush | Outperform |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-02-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-02-24 | Eingeleitet | Cowen | Outperform |
| 2020-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2020-02-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten
Black Diamond Therapeutics Inc. (BDTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider trading reveals about Black Diamond Therapeutics Inc. stockQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Black Diamond Therapeutics: Underappreciated Despite An Upcoming Key Readout (NASDAQ:BDTX) - Seeking Alpha
Will Black Diamond Therapeutics Inc. stock pay special dividends2025 Momentum Check & Reliable Intraday Trade Plans - newser.com
Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Piper Sandler - Defense World
Can Black Diamond Therapeutics Inc. stock hit record highs againJuly 2025 Review & Comprehensive Market Scan Reports - newser.com
Will Black Diamond Therapeutics Inc. stock maintain momentum in 2025July 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Volume spikes in Black Diamond Therapeutics Inc. stock – what they meanQuarterly Growth Report & Expert Curated Trade Setups - newser.com
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
It makes sense and dollars to buy Black Diamond Therapeutics Inc (BDTX) stock - Setenews
How to read the order book for Black Diamond Therapeutics Inc.Earnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com
Piper Sandler Assumes Coverage on BDTX with Overweight Rating | - GuruFocus
Tools to assess Black Diamond Therapeutics Inc.’s risk profileMarket Rally & Weekly Market Pulse Updates - newser.com
Can Black Diamond Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com
15,800 Shares in Black Diamond Therapeutics, Inc. $BDTX Bought by Bailard Inc. - Defense World
Is Black Diamond Therapeutics Inc. trending in predictive chart models2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com
Real time scanner hits for Black Diamond Therapeutics Inc. explained2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
What is HC Wainwright’s Estimate for BDTX FY2025 Earnings? - Defense World
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO) - The Globe and Mail
Black Diamond Therapeutics files for mixed shelf of up to $500 millionSEC filing - MarketScreener
Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run? - sharewise.com
Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):